Latest Period
Q4 2025
Security Snapshot
Strata Critical Medical, Inc. - Class A Stock (SRTA) Institutional Ownership
CUSIP: 092667104
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
125
Shares (Excl. Options)
52,008,284
Price
$4.81
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Class A Stock
- Symbol
- SRTA on Nasdaq
- Shares outstanding
- 85,979,314
- Price per share
- $4.04
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 52,008,284
- Total reported value
- $250,143,984
- % of total 13F portfolios
- 0%
- Share change
- +2,186,826
- Value change
- +$9,910,903
- Number of holders
- 125
- Price from insider filings
- $4.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- SRTA - Strata Critical Medical, Inc. - Class A Stock is tracked under CUSIP 092667104.
- 125 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 125 to 23 between Q4 2025 and Q1 2026.
- Reported value moved from $250,143,984 to $9,360,037.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 125 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 092667104?
CUSIP 092667104 identifies SRTA - Strata Critical Medical, Inc. - Class A Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 092667104:
Significant Owners of Strata Critical Medical, Inc. - Class A Stock (SRTA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 7.5% | $32,407,200 | 6,404,585 | ARK Investment Management LLC | 30 Sep 2025 | |||
| Third Point LLC | 5.8% | -5% | $25,300,000 | 5,000,000 | 0% | Third Point LLC | 30 Sep 2025 | |
| BlackRock, Inc. | 5.1% | +2.8% | $21,091,147 | +$760,084 | 4,384,945 | +3.7% | BlackRock, Inc. | 31 Dec 2025 |
As of 31 Dec 2025, 125 institutional investors reported holding 52,008,284 shares of Strata Critical Medical, Inc. - Class A Stock (SRTA). This represents 60% of the company’s total 85,979,314 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Strata Critical Medical, Inc. - Class A Stock (SRTA) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 8.3% | 7,110,660 | +11% | 0.23% | $34,202,275 |
| Third Point LLC | 5.8% | 5,000,000 | 0% | 0.33% | $24,050,000 |
| BlackRock, Inc. | 5.2% | 4,493,617 | +4% | 0% | $21,614,297 |
| VANGUARD GROUP INC | 4.2% | 3,633,537 | +7.5% | 0% | $17,477,313 |
| Northern Right Capital Management, L.P. | 3.3% | 2,869,014 | 3.6% | $13,799,957 | |
| AWM Investment Company, Inc. | 3.3% | 2,821,468 | 0% | 1.3% | $13,571,261 |
| First Eagle Investment Management, LLC | 2.5% | 2,129,550 | +19% | 0.02% | $10,243,136 |
| Pillsbury Lake Capital LLC | 2.3% | 1,978,252 | 0% | 3.9% | $9,515,392 |
| ROYCE & ASSOCIATES LP | 2% | 1,744,329 | +68% | 0.09% | $8,390,222 |
| Amova Asset Management Americas, Inc. | 2% | 1,677,548 | -8.3% | 0.09% | $8,052,230 |
| Sumitomo Mitsui Trust Group, Inc. | 2% | 1,677,548 | -8.3% | 0% | $8,069,006 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,654,564 | +3% | 0% | $7,960,156 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 1,444,950 | -21% | 0% | $6,950,492 |
| STATE STREET CORP | 1.5% | 1,331,512 | +1.9% | 0% | $6,404,573 |
| Uniplan Investment Counsel, Inc. | 1.5% | 1,263,987 | -0.15% | 0.61% | $6,079,777 |
| Bank of New York Mellon Corp | 1.3% | 1,117,803 | -7.8% | 0% | $5,376,632 |
| MORGAN STANLEY | 0.89% | 766,449 | -3.1% | 0% | $3,686,620 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 0.89% | 762,550 | +12% | 0.25% | $3,667,866 |
| Creek Drive Management Group LLC | 0.71% | 610,000 | 0% | 2.2% | $2,934,100 |
| RENAISSANCE TECHNOLOGIES LLC | 0.7% | 598,786 | +0.07% | 0% | $2,880,161 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.69% | 592,379 | -1.3% | 0.21% | $2,849,343 |
| NORTHERN TRUST CORP | 0.56% | 485,514 | -1.6% | 0% | $2,335,323 |
| GOLDMAN SACHS GROUP INC | 0.55% | 473,524 | +87% | 0% | $2,277,650 |
| Russell Investments Group, Ltd. | 0.42% | 360,752 | -3.6% | 0% | $1,735,217 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.41% | 348,953 | +16% | 0.04% | $1,678,464 |
Institutional Holders of Strata Critical Medical, Inc. - Class A Stock (SRTA) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,239,200 | $9,360,037 | -$785,024 | $4.18 | 23 |
| 2025 Q4 | 52,008,284 | $250,143,984 | +$9,910,903 | $4.81 | 125 |
| 2025 Q3 | 47,286,362 | $239,206,127 | +$14,930,619 | $5.06 | 136 |
| 2025 Q2 | 44,455,005 | $179,183,574 | +$8,630,071 | $4.03 | 124 |
| 2025 Q1 | 42,573,092 | $116,252,652 | -$2,666,480 | $2.73 | 117 |
| 2024 Q4 | 43,353,242 | $184,230,440 | +$11,523,087 | $4.25 | 119 |
| 2024 Q3 | 41,177,565 | $121,252,962 | +$5,683,512 | $2.94 | 119 |
| 2024 Q2 | 38,807,858 | $134,994,588 | +$4,500,006 | $3.48 | 115 |
| 2024 Q1 | 37,468,293 | $106,750,264 | +$6,028,180 | $2.85 | 112 |
| 2023 Q4 | 35,332,178 | $124,791,578 | +$3,955,619 | $3.53 | 98 |
| 2023 Q3 | 34,343,140 | $88,930,371 | -$7,931,136 | $2.59 | 101 |
| 2023 Q2 | 36,346,707 | $143,117,927 | -$1,612,269 | $3.94 | 91 |
| 2023 Q1 | 37,275,583 | $125,607,577 | -$6,294,513 | $3.38 | 88 |
| 2022 Q4 | 39,093,511 | $139,905,215 | +$648,352 | $3.58 | 91 |
| 2022 Q3 | 38,748,710 | $156,009,485 | -$2,349,790 | $4.03 | 90 |
| 2022 Q2 | 39,320,621 | $193,883,296 | +$22,393,418 | $4.46 | 86 |
| 2022 Q1 | 32,701,085 | $275,248,499 | -$27,554,097 | $8.49 | 70 |
| 2021 Q4 | 35,699,144 | $315,671,183 | +$72,718,787 | $8.83 | 77 |
| 2021 Q3 | 27,281,482 | $284,480,728 | +$37,270,022 | $10.40 | 77 |
| 2021 Q2 | 23,713,890 | $249,189,810 | +$249,182,810 | $10.50 | 74 |
| 2021 Q1 | 700 | $7,000 | $10.14 | 1 | |
| 2020 Q4 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q3 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q2 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q1 | 700 | $7,000 | $10.00 | 1 | |
| 2019 Q4 | 700 | $7,000 | $10.00 | 1 | |
| 2019 Q3 | 700 | $7,000 | $10.00 | 1 | |
| 2019 Q2 | 700 | $7,000 | $10.00 | 1 | |
| 2019 Q1 | 700 | $7,000 | $10.00 | 1 |